UK launch for first hereditary factor X deficiency treatment
The first and only treatment licensed specifically for the rare bleeding disorder hereditary factor X deficiency has now been launched across the UK.
Read More
Tag: Coagadex
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
